← Open Payments lookup

JOHN FINDLEY: Open Payments

NPI 1891777504 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$331 in 13 payments from 8 companies in 2025. Trend: 2023 $136 · 2024 $139 · 2025 $331

Food & beverage: $331
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$67
Otsuka America Pharmaceutical, Inc.2$57
E.R. Squibb & Sons, L.L.C.2$55
Janssen Pharmaceuticals, Inc2$45
ABBVIE INC.2$35
Teva Pharmaceuticals USA, Inc.1$27
Alkermes, Inc.1$26
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19

Products named: CAPLYTA, COBENFY, INVEGA SUSTENNA, VRAYLAR, REXULTI, UZEDY, ARISTADA, ABILIFY MAINTENA.

Industry payments across MA — which companies pay providers there.